Invega Lawsuits - Call Toll Free Today: (800) 846-1484

Invega (paliperidone) has been linked to the development of serious side effects in young men and boys, including growth of breasts, a condition known as gynecomastia. If your child was prescribed Invega and is suffering from the effects of gynecomastia, you can seek legal counsel from our attorneys by contacting us today.

Invega is an extended release tablet that is intended for the treatment of schizophrenia in adults and adolescents between the ages of 12 and 17. It is also prescribed in combination with mood stabilizers and/or antidepressants in some adult patients. It has not been approved for the treatment of children younger than 12.

Invega works by changing the chemicals in the brain. It is not intended for psychotic conditions related to dementia. The antipsychotic medication has been linked to heart failure, sudden death or pneumonia in elderly patients with dementia-related conditions.

Invega and Gynecomastia in Young Boys

Invega has been associated with a number of serious side effects, particularly in children. Young boys, in particular, are at an increased risk of a condition called gynecomastia, which is characterized by breast growth. Symptoms of gynecomastia include:

Surgery to fix the condition is usually required. And, although the condition is not life-threatening, it can result in severe emotional problems for young boys.

Invega Gynecomastia Lawsuits

Our attorneys have taken a special interest in Invega lawsuits involving gynecomastia in boys. The drug has not been approved in children younger than 12, but has still been prescribed to young boys, putting them at an increased risk for the development of this uncomfortable condition. If your son was prescribed Invega and has been diagnosed with gynecomastia, you may qualify to file a lawsuit on his behalf.

To learn more, contact our Invega lawyers today. We will evaluate the circumstances of your son's case and will let you know if you qualify.

First Name:
Last Name:
Phone Number:
Email Address:
Questions and Comments: